Novel immunomodulatory drugs and neo-substrates
نویسندگان
چکیده
منابع مشابه
Phosphodiesterase Inhibitors as Immunomodulatory Drugs
Los niveles intracelulares de nucleótidos cíclicos (cAMP, cGMP) tienen un papel esencial en la regulación de múltiples funciones de las células inmunes. Las fosfodiesterasas (FDEs) son un grupo grande de enzimas que ejercen un papel muy importante en la regulación de los niveles intracelulares de nucleótidos cíclicos. La pentoxifilina es un inhibidor no específico de FDE que tiene diferentes ef...
متن کاملImmunomodulatory drugs: Oral and systemic adverse effects
OBJECTIVE The main objectives are to present the different adverse effects of the immunomodulatory drugs that can impair the quality of life of the immunosuppressed patients and study the impact of immunomodulation on oral diseases. Immunomodulatory drugs have changed the treatment protocols of many diseases where immune functions play a central role, such as rheumatic diseases. Their effect on...
متن کاملImmunomodulatory effects of anti-estrogenic drugs.
There are substantial experimental, epidemiological and clinical evidences that show that breast cancer pathology is influenced by endogenous estrogens. This knowledge is the foundation upon which endocrine deprivation therapy has been developed as a major modality for the management of breast cancer. Tamoxifen, which functions as a competitive partial agonist-inhibitor of estrogen at its recep...
متن کاملInitial study of the effect of substrates on Tetrahydrozoline and its nano-constituent drugs
In this paper, the effect of halogen compounds on tetrahedrozoline with nanosized fullerene was investigated. First, the structures of Tetrahydrozoline on a fully vectorized nanoclay were optimized with halogen compounds on carbon 69 (R-X: X = F, Cl, Br; R = C60-Tetrahydrozoline-C69-). Then orbital calculations were performed using NBO technique, and structural parameters and bipolar moments of...
متن کاملNovel Mechanisms of Action for Immunomodulatory Drugs Against Multiple Myeloma : from a Tragedy to a Therapy
Thalidomide, a sedative to ease morning sickness in pregnant women, was banned more than a half century ago due to causing a severe birth defect known as phocomelia. However, the late discovery of its immunomodulatory properties have led to a new era in the treatment of Multiple Myeloma (MM), a fatal disease that back then had no effective therapy available. The recent development and FDA-accel...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomarker Research
سال: 2020
ISSN: 2050-7771
DOI: 10.1186/s40364-020-0182-y